Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types ...
First camera-agnostic motion tracking solution for laparoscopic surgery delivers real-time insight into surgical technique and proficiency across all devices and operating rooms ...
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio...
Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere. ...
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease. ...
New magnetic ablation catheter designed to enhance precision and reach in robotic electrophysiology procedures across the U.S....
Designed for greater control, streamlined usability, and longer shelf life, Sniper G3 sets a new benchmark in targeted vascular intervention....
Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research....
Collaboration aims to improve access to advanced lab testing through at-home services, supporting earlier detection and personalized care delivery....
Collaboration aims to streamline cardiac data workflows and enhance clinical decision-making through seamless EHR integration....
